Investigation Overview
January 21, 2014 (Shareholders Foundation) - An investigation on behalf of current long-term stockholders of shares of Intercept Pharmaceuticals Inc (NASDAQ:ICPT) was announced concerning whether Intercept Pharmaceuticals officers and directors possibly breached their fiduciary duties in connection with certain statements. The investigation by a law firm concerns whether certain Inte...
You must register (for free) or login to view the entire investigation.